Results 41 to 50 of about 1,341,600 (296)

ACHIEVEMENT OF MINIMAL DISEASE ACTIVITY AND PROGRESSION OF RADIOGRAPHIC CHANGES IN EARLY PSORIATIC ARTHRITIS ONE YEAR AFTER INITIATION OF TREATMENT IN «TREAT TO TARGET» STRATEGY (PRELIMINARY RESULTS OF THE REMARKA STUDY)

open access: yesНаучно-практическая ревматология, 2018
Achievement of minimal disease activity (MDA) is the main goal of the Treat-to-target (T2T) strategy in early psoriatic arthritis (ePsA). Radiographic progression in patients with ePsA treated according to the T2T strategy has been studied insufficiently.
E. Yu. Loginova   +4 more
doaj   +1 more source

DISEASE ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: A MOLDAVIAN STUDY

open access: yesArchives of the Balkan Medical Union, 2021
Introduction. Psoriatic arthritis (PsA) is an inflammatory joint disease associated in up to one-third of patients with psoriasis. Studies performed on PsA showed the high burden of the disease, but it still has not been totally quantified due to ...
Tatiana ROTARU   +6 more
doaj   +1 more source

Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib

open access: yesArthritis Research & Therapy, 2021
Background In psoriatic arthritis (PsA), further understanding of the relationships between clinical measures and patient-reported outcomes (PROs) is needed.
Laura C. Coates   +7 more
doaj   +1 more source

Characterising the role of GABA and its metabolism in the wheat pathogen Stagonospora nodorum [PDF]

open access: yes, 2015
A reverse genetics approach was used to investigate the role of γ-aminobutyric acid metabolism in the wheat pathogenic fungus Stagonospora nodorum. The creation of mutants lacking Sdh1, the gene encoding succinic semialdehyde dehydrogenase, resulted in ...
Mead, Oliver   +3 more
core   +1 more source

AB0950 Minimal disease activity in real life in psoriatic arthritis [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2018
Background Minimal disease activity (MDA) is an important target in patients with psoriatic arthritis (PsA), however it is also criticised for having low threshold for patient reported outcomes (PRO). Objectives The aim of the study was to assess the prevalence of MDA components in patients with PsA and to evaluate disease characteristics and ...
S.B. Ureyen   +10 more
openaire   +1 more source

Parallel disease activity of Behçet’s disease with renal and entero involvements: a case report

open access: yesBMC Nephrology, 2021
Background Behçet’s disease (BD) is a systemic inflammatory vasculitis with both autoimmune and autoinflammatory properties. Renal involvement in BD and its spontaneous remission have been rare.
Kanako Watanabe-Kusunoki   +8 more
doaj   +1 more source

Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus [PDF]

open access: yes, 2017
Background: The aim was to assess the attainability and outcome of the lupus low disease activity state (LLDAS) in the early stages of systemic lupus erythematosus (SLE).
CAPPELLAZZO, GIULIA   +6 more
core   +1 more source

Heterogeneity in Surface Sensing Suggests a Division of Labor in Pseudomonas aeruginosa Populations [PDF]

open access: yes, 2019
The second messenger signaling molecule cyclic diguanylate monophosphate (c-di-GMP) drives the transition between planktonic and biofilm growth in many bacterial species.
Armbuster, Catherine R.   +12 more
core   +2 more sources

Creating New β-Globin-Expressing Lentiviral Vectors by High-Resolution Mapping of Locus Control Region Enhancer Sequences. [PDF]

open access: yes, 2020
Hematopoietic stem cell gene therapy is a promising approach for treating disorders of the hematopoietic system. Identifying combinations of cis-regulatory elements that do not impede packaging or transduction efficiency when included in lentiviral ...
Aleshe, Bamidele   +14 more
core   +1 more source

The efficacy and safety of apremilast in patients with psoriatic arthritis concurrent with comorbidity in clinical practice

open access: yesНаучно-практическая ревматология, 2019
Objective: to evaluate the clinical efficacy and safety of the targeted synthetic disease-modifying antirheumatic drug (DMARD) apremilast (AP; Otesla®) in patients with active psoriatic arthritis (PsA) at 14 and 26 weeks after starting the treatment and ...
E. Yu. Loginova   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy